Cellular origins and molecular mechanisms of Barrett's esophagus and esophageal adenocarcinoma

Annals of the New York Academy of Sciences

Volumn 1300, Issue 1, 2013, Pages 187-199

  Fang, Yu ^a,b   Chen, Xiaoxin ^a,c   Bajpai, Manisha ^d   Verma, Amit ^d   Das, Kiron M ^d   Souza, Rhonda F ^e   Garman, Katherine S ^f   Donohoe, Claire L ^g   O'Farrell, Naoimh J ^g   Reynolds, John V ^g   Dvorak, Katerina ^h  

^a NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g ST JAMES S HOSPITAL   (Ireland)

^h UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Autophagy; Barrett's esophagus; DNA methylation; Esophageal adenocarcinoma; Obesity

Indexed keywords

BILE SALT; C REACTIVE PROTEIN; CYTOKINE; FIBRINOGEN; INTERLEUKIN 6; MICRORNA; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; AUTOPHAGY; BARRETT ESOPHAGUS; CARCINOGENESIS; CELL DEATH; CELL SURVIVAL; CHROMOSOME ANALYSIS; CHROMOSOME INSERTION; CLONAL VARIATION; DISEASE COURSE; DNA METHYLATION; DNA TRANSCRIPTION; EPIGENETICS; ESOPHAGEAL ADENOCARCINOMA; GENOME; HUMAN; INFLAMMATION; NONHUMAN; OBESITY; STOMACH ACID;

ANIMALIA;

EID: 84885440265     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12249     Document Type: Article

References (60)

1. Kawaura, Y., Y. Tatsuzawa, T. Wakabayashi, et al. 2001. Immunohistochemical study of p53, c-erbB-2, and PCNA in Barrett's esophagus with dysplasia and adenocarcinoma arising from experimental acid or alkaline reflux model. J. Gastroenterol. 36: 595-600.
2. Chen, X. & C.S. Yang 2009. "Barrett's esophagus-preclinical models for investigation." In: Esophageal Tumors: Principles and Practice. B.A. Jobe et al., Eds.: 61-67. New York: Demos Medical Publishing.
3. Garman, K.S., R.C. Orlando & X. Chen 2012. Review: experimental models for Barrett's esophagus and esophageal adenocarcinoma. Am. J. Physiol. Gastrointest. Liver Physiol. 302: G1231-G1243.
4. Hao, J., B. Liu, C.S. Yang, et al. 2009. Gastroesophageal reflux leads to esophageal cancer in a surgical model with mice. BMC Gastroenterol. 9: 59.
5. Watanabe, H., Y. Kominami, R. Gon, et al. 2011. Trans-differentiation of a duodenal phenotype on duodenal transplantation of different normal tissues in F344 rats. Hiroshima J. Med. Sci. 60: 1-6.
6. Kong, J., M.A. Crissey, S. Funakoshi, et al. 2011. Ectopic Cdx2 expression in murine esophagus models an intermediate stage in the emergence of Barrett's esophagus. PLoS One 6: e18280.
7. Quante, M., G. Bhagat, J.A. Abrams, et al. 2012. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell. 21: 36-51.
8. Wang, X., H. Ouyang, Y. Yamamoto, et al. 2011. Residual embryonic cells as precursors of a Barrett's-like metaplasia. Cell 145: 1023-1035.
9. Que, J., T. Okubo, J.R. Goldenring, et al. 2007. Multiple dose-dependent roles for Sox2 in the patterning and differentiation of anterior foregut endoderm. Development 134: 2521-2531.
10. Guy, N.C., H. Garewal, H. Holubec, et al. 2007. A novel dietary-related model of esophagitis and Barrett's esophagus, a premalignant lesion. Nutr. Cancer 59: 217-227.
11. Nowell, P.C. 1976. The clonal evolution of tumor cell populations. Science 194: 23-28.
12. Barrett, M.T., C.A. Sanchez, et al. 1999. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat. Genet. 22: 106-109.
13. Barrett, M.T., C.A. Sanchez, et al. 1996. Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. Oncogene 13: 1867-1873.
14. Das, K.M., Y. Kong, et al. 2011. Transformation of benign Barrett's epithelium by repeated acid and bile exposure over 65 weeks: a novel in vitro model. Int. J. Cancer 128: 274-282.
15. Bajpai, M., H. Aviv & K.M. Das Prolonged exposure to acid and bile induces chromosome abnormalities that precede malignant transformation of benign Barrett's epithelium. Mol. Cytogenet. 5: 43.
16. Kessel, R.M., M. Bajpai, T.D. Bhagat, et al. 2012. High resolution integrative analysis reveals widespread genetic and epigenetic alterations in Barrett's epithelial cells exposed to acid and bile. Gastroenterology 142: S444.
17. Garewal, H., P. Meltzer, et al. 1990. Epidermal growth factor receptor overexpression and trisomy 7 in a case of Barrett's esophagus. Dig. Dis. Sci. 35: 1115-1120.
18. Garewal, H.S., R. Sampliner, et al. 1989. Chromosomal rearrangements in Barrett's esophagus. A premalignant lesion of esophageal adenocarcinoma. Cancer Genet. Cytogenet. 42: 281-286.
19. Galipeau, P.C., D.S. Cowan, et al. 1996. 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Proc. Natl. Acad. Sci. U. S. A. 93: 7081-7084.
20. Storchova, Z. & D. Pellman 2004. From polyploidy to aneuploidy, genome instability and cancer. Nat. Rev. Mol. Cell. Biol. 5: 45-54.
21. McQuaid, K.R., L. Laine, M.B. Fennerty, et al. 2011. Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia aliment. Pharmacol. Ther. 34: 146-165.
22. Zhang, H.Y., K. Hormi-Carver, X. Zhang, et al. 2009. In benign Barrett's epithelial cells, acid exposure generates reactive oxygen species that cause DNA double-strand breaks. Cancer Res. 69: 9083-9089.
23. Huo, X., S. Juergens, X. Zhang, et al. 2011. Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-{kappa}B activation in benign Barrett's epithelial cells. Am. J. Physiol Gastrointest. Liver Physiol. 301: G278-G286.
24. Zhang, H.Y., X. Zhang, K. Hormi-Carver, et al. 2007. In non-neoplastic Barrett's epithelial cells, acid exerts early antiproliferative effects through activation of the Chk2 pathway. Cancer Res. 67: 8580-8587.
25. Dvorakova, K., C.M. Payne, L. Ramsey, et al. 2005. Apoptosis resistance in Barrett's esophagus: ex vivo bioassay of live stressed tissues. Am. J. Gastroenterol. 100: 424-431.
26. Curradi, M. et al. 2002. Molecular mechanisms of gene silencing mediated by DNA methylation. Mol. Cell. Biol. 22: 3157-3173.
27. Alvarez, H. et al. 2011. Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis. PLoS Genet 7: e1001356.
28. Shaknovich, R., M.E. Figueroa & A. Melnick 2010. HELP (HpaII tiny fragment enrichment by ligation-mediated PCR) assay for DNA methylation profiling of primary normal and malignant B lymphocytes. Methods Mol. Biol. 632: 191-201.
29. Eads, C.A. et al. 2000. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res. 60: 5021-5026.
30. Lee, O.J. et al. 2005. Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis. Neoplasia 7: 854-861.
31. Volinia, S., G.A. Calin, C.G. Liu, et al. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 103: 2257-2261.
32. Medina, P.P., M. Nolde & F.J. Slack 2010. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467: 86-90.
33. Feber, A., L. Xi, J.D. Luketich, et al. 2008. MicroRNA expression profiles of esophageal cancer. J. Thorac. Cardiovasc. Surg. 135: 255-260; discussion 60.
34. Bansal, A., I.H. Lee, X. Hong, et al. 2011. Feasibility of MicroRNAs as biomarkers for Barrett's esophagus progression: a pilot cross-sectional, phase 2 biomarker study. Am. J. Gastroenterol. 106: 1055-1063.
35. Mathe, E.A., G.H. Nguyen, E.D. Bowman, et al. 2009. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin. Cancer Res. 15: 6192-6200.
36. Wijnhoven, B.P., D.J. Hussey, D.I. Watson, et al. 2010. MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma. Br. J. Surg. 97: 853-861.
37. Lu, Z., M. Liu, V. Stribinskis, et al. 2008. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 27: 4373-4379.
38. Fassan, M., M. Pizzi, G. Battaglia, et al. 2010. Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis. J. Clin. Pathol. 63: 692-696.
39. Donohoe, C.L., G.P. Pidgeon, J. Lysaght & J.V. Reynolds 2010. Obesity and gastrointestinal cancer. Br. J. Surg. 97: 628-642.
40. Schroeder, D.D., H. Sell, M. Uhlig, et al. 2005. Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors. Diabetes 54: 2003-2011.
41. Shoelson, S.E., J. Lee & A.B. Goldfine 2006. Inflammation and insulin resistance. J. Clin. Invest. 116: 1793-1801.
42. Trayhurn, P. & I.S. Wood 2004. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutr. 92: 347-355.
43. Wajchenberg, B.L. 2000. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr. Rev. 21: 697-738.
44. Weisberg, S.P., D. McCann, M. Desai, et al. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112: 1796-1808.
45. Neels, J.G. & J.M. Olefsky 2006. Inflamed fat: what starts the fire? J. Clin. Invest. 116: 33-35.
46. Balkwill, F. 2004. Cancer and the chemokine network. Nat. Rev. Cancer 4: 540-550.
47. Sica, A., P. Allavena & A. Mantovani 2008. Cancer related inflammation: the macrophage connection. Cancer Lett. 267: 204-215.
48. Moons, L.M., J.G. Kusters, E. Bultman, et al. 2005. Barrett's oesophagus is characterized by a predominantly humoral inflammatory response. J. Pathol. 207: 269-276.
49. Nieman, D.C., D.A. Henson, S.L. Nehlsen-Cannarella, et al. 1999. Influence of obesity on immune function. J. Am. Diet. Assoc. 99: 294-299.
50. Ghanim, H., A. Aljada, D. Hofmeyer, et al. 2004. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 110: 1564-1571.
51. Jain, S.S. & R.P. Bird 2010. Elevated expression of tumor necrosis factor-alpha signaling molecules in colonic tumors of Zucker obese (fa/fa) rats. Int. J. Cancer 127: 2042-2050.
52. Zhang, Y., A. Daquinag, D.O. Traktuev, et al. 2009. White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Res. 69: 5259-5266.
53. Hursting, S.D., N.P. Nunez, L. Varticovski & C. Vinson 2007. The obesity-cancer link: lessons learned from a fatless mouse. Cancer Res. 67: 2391-2393.
54. Nguyen, G.H., A.J. Schetter, D.B. Chou, et al. 2010. Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma. Clin. Cancer Res. 16: 5824-5834.
55. Corcelle, E.A., P. Puustinen & M. Jaattela 2009. Apoptosis and autophagy: targeting autophagy signalling in cancer cells-'trick or treats'? FEBS J. 276: 6084-6096.
56. Levine, B. & G. Kroemer 2008. Autophagy in the pathogenesis of disease. Cell 132: 27-42.
57. Mathew, R., V. Karantza-Wadsworth & E. White 2007. Role of autophagy in cancer. Nat. Rev. Cancer 7: 961-967.
58. Roesly, H.B. et al. 2012. The decreased expression of Beclin-1 correlates with progression to esophageal adenocarcinoma: the role of deoxycholic acid. Am. J. Physiol. Gastrointest. Liver Physiol. 15: G864-G872.
59. Yang, H., J. Gu, K.K. Wang, et al. 2009. MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma. Clin. Cancer Res. 15: 5744-5752.
60. Fassan, M., S. Volinia, J. Palatini, et al. 2011. MicroRNA expression profiling in human Barrett's carcinogenesis. Int. J. Cancer 129: 1661-1670.